Potential Breakthrough: New Alzheimer’s Medications Display Promise in Early Disease Stages
In a potential breakthrough, two novel Alzheimer’s drugs are showcasing encouraging outcomes in slowing down the progression of the disease during its early stages. Recent research has unveiled promising results about the effectiveness of a fresh Eli Lilly medication, known as Donanemab, in curbing the advancement of Alzheimer’s by approximately 35%. For individuals in the … Read more